Where on My Body Do I Inject Mounjaro?

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide injections deliver medication through the subcutaneous layer—the fatty tissue just beneath your skin. Knowing where and how to inject correctly ensures consistent medication absorption and reduces injection-site reactions. PlexusDx compounded tirzepatide therapy is $289 per month month-to-month, or from $249/mo on the 6-month plan from licensed 503A compounding pharmacies, with nurse support included to guide your injection technique.

Approved Tirzepatide Injection Sites on Your Body

Tirzepatide injections are administered into three primary body areas: the abdomen, upper thigh, and upper arm. Each location sits over subcutaneous fatty tissue, which allows the medication to absorb steadily into your bloodstream. The abdomen—specifically the area around your navel but at least two inches away—is the most common site because it typically has consistent fat depth and is easy to access for self-injection.

Your upper thigh offers another reliable injection location, particularly the outer front or outer side of the thigh. This area provides good visibility and is simple to reach during self-injection. The upper arm, specifically the back or outer surface above the triceps, is the third approved location. Healthcare providers often recommend rotating among all three areas to prevent tissue damage and maintain consistent absorption rates.

Each injection site should be at least one inch away from previous injection locations to allow healing between doses. If you notice hardness, lumps, or discoloration at a site, pause injections in that area for at least one week before resuming.

How to Rotate Injection Sites for Safety and Effectiveness

Site rotation prevents lipohypertrophy—a condition where repeated injections in the same location create thick, fibrous tissue that reduces medication absorption. A systematic rotation pattern ensures even distribution of injections across your body. Many patients find success by dividing each body area (abdomen, thigh, arm) into four quadrants, allowing eight total zones for weekly tirzepatide doses.

A simple rotation schedule might look like this: Week 1 use the right abdomen, Week 2 the left abdomen, Week 3 the right thigh, Week 4 the left thigh, then repeat. This pattern gives each site at least four weeks between injections, allowing tissue to fully recover. Document your injection sites in a calendar or smartphone app to track rotation automatically and reduce the chance of reusing a site too quickly.

Preparing and Administering Your Tirzepatide Injection

Before injecting, wash your hands with soap and water for at least 20 seconds. Gather all materials: your tirzepatide pen or syringe, alcohol wipe, and a sterile gauze pad. Allow your medication to reach room temperature if it's been refrigerated—cold injections can increase discomfort. Never inject directly from the refrigerator, and never use medication that appears cloudy or contains particles, as compounded tirzepatide should be clear.

Select your injection site and clean it with an alcohol wipe using a circular motion, moving outward from the center. Allow the area to air dry completely—this takes about 30 seconds and prevents stinging during injection. Gently pinch the skin around your chosen site to create a raised area, insert the needle at a 90-degree angle (or 45 degrees if you have very little subcutaneous fat), and slowly press the plunger. After injection, withdraw the needle and apply gentle pressure with gauze for 5 to 10 seconds if needed.

Most patients experience minimal discomfort when using proper technique. Sharp pain or immediate bruising may indicate you've hit a blood vessel—simply apply pressure and select a different site for your next dose. Contact your PlexusDx care team if you develop signs of infection, such as increased warmth, redness, or drainage at the injection site.

What to Expect at Injection Sites and When to Contact Support

Minor redness, mild swelling, and slight bruising at the injection site are normal and typically resolve within 24 to 48 hours. These reactions are usually caused by needle trauma to small blood vessels and do not affect medication safety or efficacy. Applying ice to the area immediately after injection can reduce swelling, while warm compresses the following day may ease any lingering tenderness.

Lipodystrophy—visible dimpling or indentation of skin—occasionally occurs if sites are not rotated properly. This condition is reversible if you pause injections in the affected area for two to four weeks. Lipoatrophy, the opposite condition where fatty tissue shrinks, is rare with compounded tirzepatide but can also be managed by rotating sites and allowing affected areas to recover. PlexusDx includes nursing support to help you identify and prevent injection-site complications, and your care team is available to answer questions about your injection technique or address concerns at any time during your treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject tirzepatide into my buttocks or lower back?

No. Tirzepatide is approved only for subcutaneous injection into the abdomen, upper thigh, and upper arm. These areas provide consistent fat depth and easy access for proper technique. Injecting into unapproved areas may result in inconsistent medication absorption or tissue damage.

How do I know if I've injected tirzepatide into the right layer of skin?

Correct injection goes into subcutaneous tissue—the fatty layer beneath the epidermis and dermis. You should feel minimal resistance and no sharp pain during injection. If you hit muscle (deeper) or dermis (shallower), you may experience more discomfort. Your PlexusDx care team can review proper technique during your initial consultation.

Does injection site location affect how quickly tirzepatide works?

Tirzepatide absorption is consistent across all three approved injection sites when proper technique is used. The abdomen may absorb slightly faster than the thigh or arm, but the difference is clinically minimal. Consistent site rotation matters more than location choice for maintaining steady medication levels.

What should I do if I accidentally inject tirzepatide into the same spot twice?

One missed rotation rarely causes problems. Apply ice and avoid that site for at least two weeks to allow healing. If this becomes a pattern, it increases risk of lipohypertrophy. PlexusDx recommends using a rotation calendar or app to track injections and prevent repeated-site errors.

Can genetic factors from the Precision Peptide Genetic Test affect where I should inject?

Injection site location does not change based on genetic testing results. However, the Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights to personalize your entire tirzepatide protocol and dosing, which PlexusDx offers for $298.

Is tirzepatide from PlexusDx the same as brand-name Mounjaro?

PlexusDx tirzepatide is a compounded medication from licensed 503A compounding pharmacies, not the brand-name Mounjaro. Compounded tirzepatide has the same active ingredient and works identically, but costs $289 per month versus significantly higher brand prices. Neither compounded nor brand tirzepatide is FDA-approved; both are prescribed and used under medical supervision.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.